Stock REMI REMEDENT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Remedent, Inc.

Equities

REMI

US75954T1043

Medical Equipment, Supplies & Distribution

Delayed OTC Markets
Other stock markets
 01:41:52 2024-04-12 pm EDT 		5-day change 1st Jan Change
0.055 USD -15.84% Intraday chart for Remedent, Inc. -.--% -43.30%
2023 Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
2022 Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022 CI

Business Summary

Remedent, Inc. specializes in the research, development and manufacturing of oral care and cosmetic dentistry products. The Company designs, develops, manufactures and distributes its cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, Middle East and the United States. The Company's operating segment consists of dental products and oral hygiene products sold by Remedent Inc., Remedent N.V., and Biotech Dental Benelux N.V. The Company offers over-the-counter (OTC) tooth whitening products. It has three primary products: River 8, a prefabricated veneer; its custom-made GlamSmile Veneers and the SmileMe mirror. The Company has developed a range of prefabricated, ready-to-use veneers that the Company has branded as River8. The Company's product in the professional oral care and cosmetic dentistry is the GlamSmile veneer. The SmileMe Mirror enables the dentist to offer patients a complete Smile Consultation.

Number of employees: 3

Sales per Business

USD in Million2022Weight2023Weight Delta
Dental Products and Oral Hygiene Products
100.0 %
1 100.0 % 1 100.0 % -38.63%

Sales per region

USD in Million2022Weight2023Weight Delta
Europe and Asia
100.0 %
1 100.0 % 1 100.0 % -38.63%

Managers

Managers TitleAgeSince
Guy de Vreese CEO
 Chief Executive Officer 69 02-03-31
Philippe van Acker DFI
 Director of Finance/CFO 59 05-03-29

Members of the board

Members of the board TitleAgeSince
Fred Kolsteeg BRD
 Director/Board Member 81 02-03-31
Guy de Vreese CEO
 Chief Executive Officer 69 02-03-31
Philippe van Acker DFI
 Director of Finance/CFO 59 05-03-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 20,718,969 12,733,496 ( 61.46 %) 723,000 ( 3.490 %) 61.46 %

Company contact information

Remedent, Inc.

Zuiderlaan 1-3 Bus 8

9000, Ghent

+

http://www.remedent.com
address Remedent, Inc.(REMI)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Other Medical Equipment, Supplies & Distribution

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
REMEDENT, INC. Stock Remedent, Inc.
-43.30% 1.06M
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.07% 181B
MEDTRONIC PLC Stock Medtronic plc
+2.38% 112B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.39% 67.92B
DEXCOM, INC. Stock DexCom, Inc.
+3.81% 50.1B
CENCORA, INC. Stock Cencora, Inc.
+8.33% 44.27B
HOYA CORPORATION Stock Hoya Corporation
+9.39% 40.41B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+24.32% 31.95B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-0.25% 25.82B
TERUMO CORPORATION Stock Terumo Corporation
+17.27% 25.29B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. REMI Stock
  4. Company Remedent, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW